THE EFFECT OF ISOTRETINOIN IN 6 PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA

被引:25
作者
NEELY, SM
MEHLMAUER, M
FEINSTEIN, DI
机构
关键词
D O I
10.1001/archinte.147.3.529
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:529 / 531
页数:3
相关论文
共 18 条
[1]  
BOLLAG W, 1983, LANCET, V1, P860
[2]   RECOMBINANT LEUKOCYTE A-INTERFERON - AN ACTIVE AGENT IN ADVANCED CUTANEOUS T-CELL LYMPHOMAS [J].
BUNN, PA ;
FOON, KA ;
IHDE, DC ;
LONGO, DL ;
EDDY, J ;
WINKLER, CF ;
VEACH, SR ;
ZEFFREN, J ;
SHERWIN, S ;
OLDHAM, R .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) :484-487
[3]  
CLENDENNING WE, 1979, CANCER TREAT REP, V63, P719
[4]  
DENNERT G, 1979, J NATL CANCER I, V62, P89
[5]   EFFECTS OF RETINOIC ACID ON IMMUNE SYSTEM - STIMULATION OF T-KILLER CELL INDUCTION [J].
DENNERT, G ;
LOTAN, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1978, 8 (01) :23-29
[6]   RETINOIDS, CANCER, AND THE SKIN [J].
ELIAS, PM ;
WILLIAMS, ML .
ARCHIVES OF DERMATOLOGY, 1981, 117 (03) :160-180
[7]   INHIBITION OF ANTIBODY-DEPENDENT CELLULAR CYTO-TOXICITY AND NATURAL CYTO-TOXICITY BY RETINOIC ACID [J].
EREMIN, O ;
ASHBY, J ;
RHODES, J .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1984, 75 (01) :2-7
[8]  
Gaeke M E, 1981, Curr Probl Cancer, V6, P1, DOI 10.1016/S0147-0272(81)80004-9
[9]  
GOODMAN DS, 1984, NEW ENGL J MED, V310, P1023, DOI 10.1056/NEJM198404193101605
[10]  
HOPPE RT, 1979, CANCER TREAT REP, V63, P691